BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12483858)

  • 1. [Unverricht-Lundborg disease].
    Naito H; Wachi M
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):189-93. PubMed ID: 12483858
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features and genetics of Unverricht-Lundborg disease.
    Lehesjoki AE
    Adv Neurol; 2002; 89():193-7. PubMed ID: 11968445
    [No Abstract]   [Full Text] [Related]  

  • 3. Unverricht-Lundborg disease-a misnomer?
    Puschmann A
    Mov Disord; 2009 Mar; 24(4):629-30; author reply 630. PubMed ID: 18512745
    [No Abstract]   [Full Text] [Related]  

  • 4. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
    Santoshkumar B; Turnbull J; Minassian BA
    Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperostosis frontalis interna as a novel finding in Unverricht-Lundborg disease.
    Korja M; Kaasinen V; Lamusuo S; Marttila RJ; Parkkola R
    Neurology; 2007 Mar; 68(13):1077-8. PubMed ID: 17389316
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular background of EPM1-Unverricht-Lundborg disease.
    Joensuu T; Lehesjoki AE; Kopra O
    Epilepsia; 2008 Apr; 49(4):557-63. PubMed ID: 18028412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unverricht-Lundborg disease (EPM1).
    Genton P
    Epilepsia; 2010 Feb; 51 Suppl 1():37-9. PubMed ID: 20331711
    [No Abstract]   [Full Text] [Related]  

  • 9. Unverricht-Lundborg disease: homozygosity for a new splicing mutation in the cystatin B gene.
    Pinto E; Freitas J; Duarte AJ; Ribeiro I; Ribeiro D; Lima JL; Chaves J; Amaral O
    Epilepsy Res; 2012 Mar; 99(1-2):187-90. PubMed ID: 22154554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression.
    Franceschetti S; Sancini G; Buzzi A; Zucchini S; Paradiso B; Magnaghi G; Frassoni C; Chikhladze M; Avanzini G; Simonato M
    Neurobiol Dis; 2007 Mar; 25(3):675-85. PubMed ID: 17188503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unverricht-Lundborg disease with cystatin B gene abnormalities.
    Kagitani-Shimono K; Imai K; Okamoto N; Ono J; Okada S
    Pediatr Neurol; 2002 Jan; 26(1):55-60. PubMed ID: 11814737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
    Kim KH; Song JS; Park CW; Ki CS; Heo K
    Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
    Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
    Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficult differential diagnosis of Unverricht-Lundborg disease with spontaneous kinesogenic myoclonus and movement disorder.
    Rana AQ; Ali A; Böke BN
    Acta Neurol Belg; 2012 Dec; 112(4):383-4. PubMed ID: 22539245
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein therapy for Unverricht-Lundborg disease using cystatin B transduction by TAT-PTD. Is it that simple?
    Andrade DM; Scherer SW; Minassian BA
    Epilepsy Res; 2006 Nov; 72(1):75-9. PubMed ID: 16930946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased cortical excitability in Unverricht-Lundborg disease in the long-term follow-up: a consecutive SEP study.
    Kobayashi K; Matsumoto R; Kondo T; Kawamata J; Hitomi T; Inouchi M; Matsuhashi M; Takahashi R; Ikeda A
    Clin Neurophysiol; 2011 Aug; 122(8):1617-21. PubMed ID: 21353634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA deamination enables direct PCR amplification of the cystatin B (CSTB) gene-associated dodecamer repeat expansion in myoclonus epilepsy type Unverricht-Lundborg.
    Weinhaeusel A; Morris MA; Antonarakis SE; Haas OA
    Hum Mutat; 2003 Nov; 22(5):404-8. PubMed ID: 14517952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Univerricht-Lundborg disease: underdiagnosed in the Netherlands.
    de Haan GJ; Halley DJ; Doelman JC; Geesink HH; Augustijn PB; Jager-Jongkind AD; Majoie M; Bader AJ; Leliefeld-Ten Doeschate LA; Deelen WH; Bertram E; Lehesjoki AE; Lindhout D
    Epilepsia; 2004 Sep; 45(9):1061-3. PubMed ID: 15329070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein aggregation as a possible cause for pathology in a subset of familial Unverricht-Lundborg disease.
    Ceru S; Rabzelj S; Kopitar-Jerala N; Turk V; Zerovnik E
    Med Hypotheses; 2005; 64(5):955-9. PubMed ID: 15780491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizures, ataxia, and neuronal loss in cystatin B heterozygous mice.
    Kaasik A; Kuum M; Aonurm A; Kalda A; Vaarmann A; Zharkovsky A
    Epilepsia; 2007 Apr; 48(4):752-7. PubMed ID: 17319918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.